LPL Financial’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.5K Buy
16,956
+4,759
+39% +$9.69K ﹤0.01% 5256
2025
Q1
$19.9K Buy
+12,197
New +$19.9K ﹤0.01% 5121
2024
Q1
Sell
-1,357
Closed -$8.3K 4888
2023
Q4
$8.3K Buy
1,357
+61
+5% +$373 ﹤0.01% 4698
2023
Q3
$6.05K Sell
1,296
-246
-16% -$1.15K ﹤0.01% 4609
2023
Q2
$8.26K Sell
1,542
-121
-7% -$648 ﹤0.01% 4514
2023
Q1
$16.4K Sell
1,663
-1,292
-44% -$12.7K ﹤0.01% 4398
2022
Q4
$55.3K Sell
2,955
-70
-2% -$1.31K ﹤0.01% 4220
2022
Q3
$63K Sell
3,025
-341
-10% -$7.1K ﹤0.01% 4164
2022
Q2
$70K Sell
3,366
-2,666
-44% -$55.4K ﹤0.01% 4156
2022
Q1
$260K Buy
6,032
+1,736
+40% +$74.8K ﹤0.01% 3667
2021
Q4
$257K Buy
4,296
+168
+4% +$10.1K ﹤0.01% 3791
2021
Q3
$355K Sell
4,128
-1,109
-21% -$95.4K ﹤0.01% 3495
2021
Q2
$583K Buy
5,237
+943
+22% +$105K ﹤0.01% 3016
2021
Q1
$478K Buy
4,294
+463
+12% +$51.5K ﹤0.01% 3047
2020
Q4
$407K Buy
3,831
+82
+2% +$8.71K ﹤0.01% 2930
2020
Q3
$522K Sell
3,749
-2,186
-37% -$304K ﹤0.01% 2410
2020
Q2
$1.92M Buy
5,935
+1,263
+27% +$408K ﹤0.01% 1365
2020
Q1
$417K Buy
4,672
+1,330
+40% +$119K ﹤0.01% 2211
2019
Q4
$132K Buy
3,342
+425
+15% +$16.8K ﹤0.01% 3170
2019
Q3
$72K Buy
2,917
+1,184
+68% +$29.2K ﹤0.01% 3171
2019
Q2
$61K Buy
+1,733
New +$61K ﹤0.01% 3174
2016
Q3
Sell
-933
Closed -$103K 2692
2016
Q2
$103K Sell
933
-919
-50% -$101K ﹤0.01% 2503
2016
Q1
$198K Buy
1,852
+735
+66% +$78.6K ﹤0.01% 2796
2015
Q4
$84K Buy
1,117
+173
+18% +$13K ﹤0.01% 3011
2015
Q3
$70K Buy
944
+67
+8% +$4.97K ﹤0.01% 2692
2015
Q2
$83K Sell
877
-210
-19% -$19.9K ﹤0.01% 2771
2015
Q1
$110K Buy
+1,087
New +$110K ﹤0.01% 2666
2014
Q2
Sell
-290
Closed -$46K 2715
2014
Q1
$46K Buy
+290
New +$46K ﹤0.01% 2592